Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Aminolevulinic Acid × Sarcoma × Clear all

Phase

Phase 2 4 Phase 1 2 Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1 Dermatologic 1 CNS 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 6 pembrolizumab 3 Specimen Handling 3 Radiotherapy 3 Oncolytic Virotherapy 3 Nivolumab 3 Irinotecan 3 Cyclophosphamide 3 X-Rays 2 Temozolomide 2 Etoposide 2 Doxorubicin 2 Biopsy 2 Bevacizumab 2 trastuzumab biosimilar HLX02 1 sodium thiosulfate 1 romiplostim 1 pertuzumab 1 perflutren 1 palbociclib 1 olaparib 1 niraparib 1 montelukast 1 glucarpidase 1 gamma-Glutamyl Hydrolase 1 fluorodopa F 18 1 eribulin 1 entrectinib 1 entacapone 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡